Marianne Brodmann

Marianne Brodmann is an Austrian physician and academic specializing in angiology and vascular medicine. She has spent her professional career in Austria, where she has combined clinical leadership with an active role in international cardiovascular and vascular research. Her work has focused on advancing the diagnosis and treatment of peripheral vascular disease through both clinical innovation and research.

Academic History

Dr Brodmann trained in internal medicine and angiology, developing expertise in vascular biology, thrombosis, and endovascular therapies. She has been appointed to senior academic and clinical positions at the Medical University of Graz, Austria, where she has contributed extensively to medical education, research, and specialist training in angiology.

Career Overview

Dr Brodmann serves as Head of the Division of Angiology and Head of Clinical Research within the Division of Angiology at the Medical University of Graz. In these roles, she has led clinical services and research programs focused on vascular disease, while fostering multidisciplinary collaboration between clinicians, researchers, and industry partners.

She is a Fellow of the European Society of Cardiology and has held important leadership roles within professional organizations. These include serving as a Board Member of the European Union of Medical Specialists, past President of the Austrian Society of Angiology, and National Delegate of the International Union of Angiology. Through these positions, she has contributed to professional standards, education, and policy development in vascular medicine at both national and international levels.

Dr Brodmann’s research interests include anticoagulation and thrombolysis, the development and evaluation of new endovascular technologies for peripheral arterial disease, and the investigation of restenosis mechanisms following vascular interventions. She founded a dedicated research establishment for experimental angiology animal models at the University of Graz, enabling translational research bridging laboratory findings and clinical application.

She has participated in more than 50 international clinical trials and has served as Principal Investigator for major studies including the Bioflex I, Lutonix BTK, and TOBA-BTK clinical trials. In addition, she has been a member of steering committees for large international trials such as the CVI Ingenuity study, contributing to trial design, execution, and interpretation of outcomes.

Career Timeline

• Early career: Training in internal medicine and angiology in Austria
• Academic appointment: Joined the Medical University of Graz and advanced to senior clinical and research leadership role
• Leadership roles: Appointed Head of the Division of Angiology and Head of Clinical Research at the Medical University of Graz
• Professional societies: Served as past President of the Austrian Society of Angiology and National Delegate of the International Union of Angiology
• Current: Continues clinical, academic, and research leadership in vascular medicine and angiology

Recognition

Dr Brodmann is widely recognized for her contributions to angiology and peripheral vascular research. Her leadership in international clinical trials and professional societies reflects her standing as a key opinion leader in vascular medicine. She is frequently invited to speak at international congresses and has contributed to numerous peer-reviewed publications focused on endovascular therapy and vascular disease management.

Areas of Speciality

• Angiology
• Peripheral arterial disease
• Anticoagulation and thrombolysis
• Endovascular therapies
• Restenosis and vascular remodeling
• Clinical trials in vascular medicine
• Experimental and translational angiology research

References

• https://www.medunigraz.at/en/angiology
• https://www.escardio.org/The-ESC/Leadership/Fellows-of-the-ESC
• https://pubmed.ncbi.nlm.nih.gov/?term=Brodmann+M
• https://angiology.org/about-iua/leadership